Wall Street Hates These Stocks, While Goldman Sachs Says They’re Worth It

This tricky market is making it difficult to find great opportunities, so Goldman Sachs thinks that these underappreciated gems with great potential might be worth looking into since they seem to be sitting on a lot of cash.

‍

There were a number of stocks selected by the Wall Street bank that its analysts were bullish on, but the rest of the Street rated as neutral or as sells on these stocks. The firms' earnings estimates for these companies are at least 2% over consensus for the stocks with Goldman buy ratings. Based on Goldman's price target, the firm believes these stocks have at least a 10% upside potential.

‍

“Investing in these names would be a good opportunity for contrarian investors to generate alpha since they appear underappreciated by the market,” said Goldman.

‍

• Lincoln National Corp.

‍

• Gap

‍

• Lyft

‍

• BigCommerce

‍

• Macy's

‍

• Amgen

‍

• Mosaic

‍

• Appian Corp.

‍

• Willis Towers Watson

‍

• PPG Industries

‍

The top of the list is occupied by the insurance company Lincoln National. In spite of Goldman's belief that the stock will rise nearly 80% in the next 12 months, only 6% of analysts rated the stock as a buy. There has been a decline of more than 32% in the stock price this year alone.

‍

Among the names on the out-of-concurrency list are retail giants Gap and Macy's. According to Macy's, the department store operator recently reported a higher profit than it had expected for the holiday quarter, but it has stated that it expects a more difficult year in the future.

‍

Wall Street, with the exception of Goldman Sachs, also generally hates ride-share giant Lyft. As part of its efforts to restructure the company, Lyft released weak guidance last month. As part of the announcement, Lyft also announced that the founders of the company, CEO Logan Green and President John Zimmer, would be stepping down from their roles on a day-to-day basis very soon. David Risher, a former executive at Amazon, will be taking the reins of the organization on April 17.

‍

The following were also differentiated ideas from Goldman Sachs: Amgen, Mosaic, Appian, and Willis Towers Watson.

‍